InvestorWire NewsRoom

Article

Real-World Evidence and Market Access Symposium Features Timely Advisement During COVID Era
April 13, 2021

Real-World Evidence and Market Access Symposium Features Timely Advisement During COVID Era

  • Organized by Dynamic Global Events (“DGE”), a market research and event outreach organization with experience in relevant B2B life science conferences
  • Taking place April 14-15 with an online, live-streamed format
  • Experts from some two dozen organizations and companies addressing timely real-world evidence (“RWE”) applicable to the COVID-19 pandemic’s disruptive effect on societies
  • A potential tool for preparing to transform regulatory submissions, clinical decision making and value demonstrations

Dynamic Global Events (“DGE”) will leverage its extensive market research, targeted outreach and content-driven team’s experience to deliver the latest in a series of relevant B2B events within the life sciences arena, focusing on data analytics during the two-day Real-World Evidence & Market Access Symposium. 

The symposium will take place April 14 and 15, involving a livestream audience with interests in clinical applications and the lessons derived from using real-world evidence (“RWE”) during the ongoing COVID-19 pandemic.

The novel nature of the pandemic also made it necessary for scientists to continually re-evaluate their findings in order to issue the best advisory information to the public. But the pandemic’s disruptive forces have also opened the door to significant new developments in the life sciences arena that might have been unthought of just a couple of years ago, including strategies on how to develop confidence in unfolding science.

DGE’s Real World Evidence and Market Access Symposium addresses topics such as applying RWE to communications strategies to achieve launch excellence, establishing what evidence can support new indications or labeling, informing clinical trial design innovation and precise patient targeting and screening, developing the potential of AI and machine learning to predict, diagnose, treat and prevent disease, and using RWE to support product effectiveness for payers and prescribers, as well as improving reimbursement models.

The symposium’s insights will prove particularly useful to companies and organizations in helping them to prepare for potential FDA 2021 draft guidance on real-world evidence. More than two dozen speaking faculty members hailing from international biopharmaceutical companies, RWE technology platforms and research universities will broaden attendees’ understanding of immediately relevant RWE matters.

For more information, visit the symposium’s web portal at https://dgevents.com/event/real-world-evidence-market-access-symposium/.

To receive a discount on your registration, use code IBN2021.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Recent Articles

Release Categories

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(310) 299-1717

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).